Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts"

ROCKET AF Steering Committee and Investigators; Jonathan P Piccini; Susanna R Stevens; Yuchiao Chang; Daniel E Singer; Yuliya Lokhnygina; Alan S Go; Manesh R Patel; Kenneth W Mahaffey; Jonathan L Halperin; Günter Breithardt; Graeme J Hankey; Werner Hacke; Richard C Becker; Christopher C Nessel; Keith A A Fox; Robert M Califf

doi:10.1161/CIRCULATIONAHA.113.004013

Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts"

ROCKET AF Steering Committee and Investigators, Jonathan P Piccini, Susanna R Stevens, Yuchiao Chang, Daniel E Singer, Yuliya Lokhnygina, Alan S Go, Manesh R Patel, Kenneth W Mahaffey, Jonathan L Halperin, Günter Breithardt, Graeme J Hankey, Werner Hacke, Richard C Becker, Christopher C Nessel, Keith A A Fox, Robert M Califf

Research output: Contribution to journal › Letter

Original language	English
Pages (from-to)	e172-3
Journal	Circulation Research
Volume	128
Issue number	11
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.113.004013
Publication status	Published - 10 Sept 2013

Keywords / Materials (for Non-textual outputs)

Atrial Fibrillation
Embolism
Factor Xa
Female
Humans
Male
Morpholines
Stroke
Thiophenes
Vitamin K

Access to Document

10.1161/CIRCULATIONAHA.113.004013

Cite this

ROCKET AF Steering Committee and Investigators, Piccini, J. P., Stevens, S. R., Chang, Y., Singer, D. E., Lokhnygina, Y., Go, A. S., Patel, M. R., Mahaffey, K. W., Halperin, J. L., Breithardt, G., Hankey, G. J., Hacke, W., Becker, R. C., Nessel, C. C., Fox, K. A. A., & Califf, R. M. (2013). Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts". Circulation Research, 128(11), e172-3. https://doi.org/10.1161/CIRCULATIONAHA.113.004013

ROCKET AF Steering Committee and Investigators ; Piccini, Jonathan P ; Stevens, Susanna R et al. / Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation : validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts". In: Circulation Research. 2013 ; Vol. 128, No. 11. pp. e172-3.

@article{dc5a807c11ec4dbfacff7282141c7774,

title = "Response to letter regarding article, {"}renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts{"}",

keywords = "Atrial Fibrillation, Embolism, Factor Xa, Female, Humans, Male, Morpholines, Stroke, Thiophenes, Vitamin K",

author = "{ROCKET AF Steering Committee and Investigators} and Piccini, {Jonathan P} and Stevens, {Susanna R} and Yuchiao Chang and Singer, {Daniel E} and Yuliya Lokhnygina and Go, {Alan S} and Patel, {Manesh R} and Mahaffey, {Kenneth W} and Halperin, {Jonathan L} and G{\"u}nter Breithardt and Hankey, {Graeme J} and Werner Hacke and Becker, {Richard C} and Nessel, {Christopher C} and Fox, {Keith A A} and Califf, {Robert M}",

year = "2013",

month = sep,

day = "10",

doi = "10.1161/CIRCULATIONAHA.113.004013",

language = "English",

volume = "128",

pages = "e172--3",

journal = "Circulation Research",

issn = "0009-7330",

publisher = "Lippincott Williams and Wilkins",

number = "11",

}

ROCKET AF Steering Committee and Investigators, Piccini, JP, Stevens, SR, Chang, Y, Singer, DE, Lokhnygina, Y, Go, AS, Patel, MR, Mahaffey, KW, Halperin, JL, Breithardt, G, Hankey, GJ, Hacke, W, Becker, RC, Nessel, CC, Fox, KAA & Califf, RM 2013, 'Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts"', Circulation Research, vol. 128, no. 11, pp. e172-3. https://doi.org/10.1161/CIRCULATIONAHA.113.004013

Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts". / ROCKET AF Steering Committee and Investigators; Piccini, Jonathan P; Stevens, Susanna R et al.
In: Circulation Research, Vol. 128, No. 11, 10.09.2013, p. e172-3.

Research output: Contribution to journal › Letter

TY - JOUR

T1 - Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation

T2 - validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts"

AU - ROCKET AF Steering Committee and Investigators

AU - Piccini, Jonathan P

AU - Stevens, Susanna R

AU - Chang, Yuchiao

AU - Singer, Daniel E

AU - Lokhnygina, Yuliya

AU - Go, Alan S

AU - Patel, Manesh R

AU - Mahaffey, Kenneth W

AU - Halperin, Jonathan L

AU - Breithardt, Günter

AU - Hankey, Graeme J

AU - Hacke, Werner

AU - Becker, Richard C

AU - Nessel, Christopher C

AU - Fox, Keith A A

AU - Califf, Robert M

PY - 2013/9/10

Y1 - 2013/9/10

KW - Atrial Fibrillation

KW - Embolism

KW - Factor Xa

KW - Female

KW - Humans

KW - Male

KW - Morpholines

KW - Stroke

KW - Thiophenes

KW - Vitamin K

U2 - 10.1161/CIRCULATIONAHA.113.004013

DO - 10.1161/CIRCULATIONAHA.113.004013

M3 - Letter

C2 - 24019452

SN - 0009-7330

VL - 128

SP - e172-3

JO - Circulation Research

JF - Circulation Research

IS - 11

ER -

ROCKET AF Steering Committee and Investigators, Piccini JP, Stevens SR, Chang Y, Singer DE, Lokhnygina Y et al. Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts". Circulation Research. 2013 Sept 10;128(11):e172-3. doi: 10.1161/CIRCULATIONAHA.113.004013